Daniel Stover, MD, FASCO
@StoverLab
Breast cancer physician-scientist | Clinical computational oncology @OSUCCC_James | Vice Chair, @Alliance_org Breast Cmte | Views own | https://t.co/43RiVpzkfP
ID:806257453088305152
https://u.osu.edu/stoverlab 06-12-2016 22:02:11
4,2K Tweets
5,2K Followers
1,8K Following
“What if I do nothing?”
Who didn't have that thought cross their mind when diagnosed w/ cancer?
Interesting work by Jennifer Plichta MD (she/her) Shelley Hwang Duke Cancer
link.springer.com/article/10.100…
'Survival among patients with untreated metastatic breast cancer: ''What if I do nothing?''
Great #TumorBoardTuesday on hormone receptor negative, HER2low breast cancer.
Always some nice ‘nuggets’, figures, and review! Great work by Nerea Lopetegui-Lia, MD Margaret Gatti-Mays MD MPH FACP & the #TumorBoardTuesday team
📍In metastatic #TNBC , biopsy site matters! 📍
Things to keep in mind when trying to determine #IO benefit/eligibility
Nerea Lopetegui-Lia, MD Margaret Gatti-Mays MD MPH FACP Pelotonia Institute for Immuno-Oncology Ohio State Medical Oncology
Excited to be in Chapel Hill today for UNC Lineberger Cancer Center Grand Rounds 💻🧬
But had to start my day with a run through the beautiful UNC campus & past the Old Well!
I always learn something new from #TumorBoardTuesday - Excited to join tomorrow!
Margaret Gatti-Mays MD MPH FACP Nerea Lopetegui-Lia, MD The James Ohio State Medical Oncology
Excited to see Arya Roy co-leading this effort to help us understand & advance workforce diversity! Way to bring data to an important issue
And, so excited Arya Roy is joining The James Breast Onc Team this fall💯
CC: Margaret Gatti-Mays MD MPH FACP Sagar Sardesai Dionisia Quiroga, DO, PhD Nicole Williams MD
So excited to do #tumorboardtuesday with #RisingStar Nerea Lopetegui-Lia, MD ClevelandClinicNews and discuss #mBC #HER2low #bcsm The James Ohio State Medical Oncology on Tuesday 4/16
Amazing resource! Single cell atlas of breast cancer - can’t wait to check this out.
Congratulations to Isaac Chan, MD, PhD lab & collaborators incl Sangeetha Reddy Heather McArthur, MD, MPH Christine Hodgdon Evanthia Roussos Torres, MD, PhD UTSW Simmons Cancer Center !
#bcsm OncoAlert
So proud of Vishnu Prasath, MD, MS - an *amazing* PSTP house staff The Ohio State University College of Medicine who presented NCI9455 & correlatives as 1st author at #AACR2024 .
Still seeking to understand the RAS/MEK/ERK pathway & #TNBC ...but all data takes us one step closer.
The James Pelotonia The Ohio State University Wexner Medical Center
Our study on the prognosis of small TNBCs is out in npj Journals Breast. Among 8601 pts with stage I TNBC in SEER, we found excellent 5-year outcomes, with a significant BCSS benefit for chemo in pT1c. Benefit less clear in tumors ≤1cm: biomarkers needed! nature.com/articles/s4152…
This is a critical need. Why is histologic subtype so rarely reported? Why so few subset analyses?
Thanks to Christine Desmedt and colleagues for highlighting this!
CC: Dr. Steffi Oesterreich Matthew J. Sikora, PhD